Alivus Life Sciences Q2 FY27: EBITDA up 47.0% YoY to Rs. 2,851 Mn, EBITDA margin at record 41.8%
Alivus Life Sciences says Q2 FY27 EBITDA rose 47.0% YoY to Rs. 2,851 Mn, with margin at a record high of 41.8%.
By ScoutQuest · · 1 min read
- EBITDA growth
- Q2 FY27 EBITDA rose 47.0% YoY to Rs. 2,851 Mn
- EBITDA margin
- margin at a record high of 41.8%
- Non-GPL business growth
- non-GPL business grew 20.8% YoY in Q2 FY27
- Release
- Results press release
- Period
- Q2 FY27
_Standalone · Q2 & H1 FY27_
📈 The company says Q2 FY27 EBITDA rose 47.0% YoY to Rs. 2,851 Mn, with EBITDA margin at a record high of 41.8%, up 880 bps YoY and 520 bps QoQ.
📌 The company says its non-GPL business grew 20.8% YoY in Q2 FY27, and MD & CEO Dr. Yasir Rawjee said the CDMO business saw a meaningful pick-up during the quarter.
🏭 The company says construction of Phase 1 at Solapur, covering 340 KL of intermediate block and backward integration capacity, is expected to be completed in Q3 FY27, and Phase 2, a 125 KL API/pharma block, in Q4 FY27.
📌 The company held cash and cash equivalents, including short-term investments, of Rs. 10,116 Mn as of September 30, 2026.
Also from Alivus Life Sciences
Alivus Life Sciences uploads audio recording of Q2 FY2027 earnings call held October 30, 2026
30 Oct 2026
Alivus Life Sciences Q2 FY27: revenue up 16.0% to ₹6,820 Mn, PAT up 51.3% as margins expand
29 Oct 2026
Standalone results for the 30 Sep'26
29 Oct 2026
More numbers
- Revenue from operations, Q2 FY27Rs. 6,820 Mn
- Revenue from operations, H1 FY27Rs. 13,224 Mn
- PAT, Q2 FY27Rs. 1,968 Mn
- PAT, H1 FY27Rs. 3,569 Mn
- EBITDA, Q2 FY27Rs. 2,851 Mn
- EBITDA margin, Q2 FY2741.8%
- PAT margin, Q2 FY2728.9%
- Cash and cash equivalents incl. short-term investmentsRs. 10,116 Mn
- Cumulative DMF/CEP updates630
- Non-GPL business growth, Q2 FY2720.8%
- Solapur Phase 1 capacity340 KL
- Solapur Phase 2 capacity125 KL
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.